At a glance
ClinicalIndex Comparison RecordN/ACompleted· 46 enrolled
Drug / intervention
lactulose:mannitol (L:M) oral challengedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intestinal Permeability and Endometriosis
In Brief
An observational study evaluating lactulose:mannitol (L:M) oral challenge for Endometriosis. Completed, enrolled 46 participants across 2 sites.
Detailed Summary
The objective of this project will be to determine whether patients with a surgical diagnosis of endometriosis have impaired intestinal permeability as compared with healthy controls. This would suggest the presence of an environmentally triggered and intestinally mediated association in the etiology of endometriosis. This would be a proof of concept trial to establish whether there is in fact a relationship worthy of future research.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedFeb 2017
Primary CompletionJun 2019
TodayJul 2026
First PostedFeb 3, 2017
Enrollment StartApr 1, 2016
Primary CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 9.4 years ago
Interventions
lactulose:mannitol (L:M) oral challengedrug